KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) EPS (Basic) (2016 - 2025)

Quest Diagnostics' EPS (Basic) history spans 17 years, with the latest figure at $2.21 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 11.62% year-over-year to $2.21; the TTM value through Dec 2025 reached $8.87, up 14.01%, while the annual FY2025 figure was $8.87, 14.01% up from the prior year.
  • EPS (Basic) for Q4 2025 was $2.21 at Quest Diagnostics, up from $2.18 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $5.05 in Q2 2021 and bottomed at $0.93 in Q4 2022.
  • The 5-year median for EPS (Basic) is $2.06 (2023), against an average of $2.41.
  • The largest annual shift saw EPS (Basic) skyrocketed 375.68% in 2021 before it plummeted 71.12% in 2022.
  • A 5-year view of EPS (Basic) shows it stood at $3.22 in 2021, then tumbled by 71.12% to $0.93 in 2022, then surged by 84.95% to $1.72 in 2023, then rose by 15.12% to $1.98 in 2024, then rose by 11.62% to $2.21 in 2025.
  • Per Business Quant, the three most recent readings for DGX's EPS (Basic) are $2.21 (Q4 2025), $2.18 (Q3 2025), and $2.51 (Q2 2025).